investing.comOCT 192 min read$MXL

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

Original reporting

investing.com

Published Oct 19, 2026, 2:44 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 19, 2026, 2:56 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefFinancial news

Primary signal

$MXL

Bullish

high confidence

Mentioned

$MXL · $SNEX

Relevance

7/10

AlphAI data visualization · based on investing.com

Decision brief

The 30-second read

$MXLBullishMed

Why it matters

Analyst endorsement could attract short‑term buying ahead of the earnings release.

Market read

The new Buy rating provides a near‑term trade idea for MXL before its upcoming earnings.

What to watch

Potential supply‑chain constraints and competitive pressure from larger IC vendors.

Relevance 7/10Novelty 6/10Timing: before earnings release on Oct 22

Background

StoneX's reiteration follows an S&P upgrade and recent strong infrastructure revenue growth.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$MXLBullishHigh confidence

Context

StoneX reiterated a Buy rating and raised the price target to $125 ahead of MaxLinear's earnings report.

Expected impact

likely upward pressure as investors act on the new Buy rating

Evidence & confidence

The rating change is fresh and provides a concrete catalyst before the earnings release.

Market effects

Sector

Positive sentiment may spill to other RF and mixed‑signal IC peers.

Regional

Limited to US semiconductor sector.

Global

Minor; primarily affects US‑listed chip makers.

Counterpoint

What could challenge this read

The rating may be premature if earnings miss expectations.

Key entities

company
MaxLinear
RF and mixed‑signal IC designer.
analyst
StoneX
Research firm issuing the Buy rating.

Read at source ← All news

OCT 16

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

investing.com1 min

OCT 15

$ONMed

Onsemi started at Buy at StoneX, sees 54% upside on chip growth (ON:NASDAQ)

StoneX initiated coverage of ON Semiconductor (ON) with a Buy rating, citing potential benefits from semiconductor demand recovery and growth in automotive and AI data center power systems. The stock is down 3% in premarket trading.

seekingalpha.com1 min

OCT 15

$ONMed

ON Stock Draws Bullish Initiation From StoneX — Analyst Sees Nearly 50% Upside On Broadening Chip Recovery

Onsemi (ON) guided Q3 revenue between $1.65B and $1.75B, up from $1.6B in Q2. StoneX initiated coverage with a bullish outlook, suggesting nearly 50% upside. Retail sentiment on Stocktwits is 'extremely bearish,' despite a 29% year-to-date rally for ON shares, compared to a 65% rise in the iShares Semiconductor ETF (SOXX).

finance.yahoo.com1 min

OCT 14

$DPZMed

StoneX maintains Buy rating on Domino's Pizza, $400 price target

StoneX maintained a Buy rating on Domino's Pizza (DPZ) with a $400 price target, implying a 35.1% upside from the Oct 13 close. The firm cited strong traffic growth drivers and attractive valuation relative to historical ranges. Recent analyst price targets for DPZ range from $320 to $425.

tradingview.com1 min

OCT 12

$SECZMed

Securitize Price Target Rises 50% to $18 at StoneX

StoneX raised its price target for Securitize (NYSE: SECZ) to $18 from $12, citing its expansion into blockchain-based securities markets. The company launched a platform for trading tokenized U.S. stocks, including Apple, Nvidia, Microsoft, and Tesla. Securitize reported $4.3B in tokenized assets under management and $5.3B in transaction volume, but revenue declined 5% to $14.4M with a net loss of $21.7M.

tronweekly.com2 min

OCT 10

MedAI 8/10

Sandisk and MaxLinear: Rising Stars in Tech Stocks

Sandisk reported 372% YoY revenue growth in Q4 2026, with Q1 2027 projections at 20% sequential growth. MaxLinear saw 55% YoY revenue growth in Q2 2027, with Q3 guidance up to $220M. Both companies are positioned in high-demand tech sectors, with Sandisk in NAND flash memory and MaxLinear in AI-driven data center microchips.

intellectia.ai2 min